2OK.F SPECTRACURE AB

Healthcare Health Care Equipment & Supplies Frankfurt Exchange
0.0001 EUR
Close of Nov 3, 2026
0.0001 0.0063
Market cap
EUR 73.5K
P/E
-
P/B
0.01x
ROE
-27.7%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is 2OK.F undervalued?

Graham number

The Graham number of SPECTRACURE AB cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

SPECTRACURE AB fundamental analysis

No fundamental analysis for SPECTRACURE AB yet.

SPECTRACURE AB stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About SPECTRACURE AB

SpectraCure AB (publ) engages in the development of cancer treatment system in Sweden. It develops Q-PRO, a laser unit; IDOSE software platform, which calculates the optimal laser light dose and placement of the optical fibers; and disposable items comprising needles, optical fibers, and light-sensitive medication. The company was incorporated in 2003 and is based in Lund, Sweden.

Full company profile